World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
60
Citations
10773
World Ranking
3174
National Ranking
1254

Overview

Karl V. Clemons is affiliated with Stanford University in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Epidemiology, Small Animals, Pulmonary and Respiratory Medicine, and Plant Science.

Their work covers a range of topics including:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Infectious Diseases and Mycology
  • Nail Diseases and Treatments
  • Cystic Fibrosis Research Advances
  • Nematode management and characterization studies

Karl V. Clemons has authored several recent papers published in respected journals. These include:

  • Interplay of Cytokines and Chemokines in Aspergillosis, 2024, Journal of Fungi
  • Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis, 2021, Antimicrobial Agents and Chemotherapy
  • Protective Role of CFTR during Fungal Infection of Cystic Fibrosis Bronchial Epithelial Cells with Aspergillus fumigatus, 2023, Frontiers in Cellular and Infection Microbiology

Frequent co-authors with whom they have collaborated on multiple occasions include:

  • David A. Stevens
  • Gabriele Sass
  • Jata Shankar
  • Raman Thakur
  • Laura Kovanda

The venues where Karl V. Clemons regularly publishes include:

  • Journal of Fungi
  • Antimicrobial Agents and Chemotherapy
  • Frontiers in Cellular and Infection Microbiology

Best Publications

  • Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth

    James Kim;Jean Y. Tang;Jean Y. Tang;Ruoyu Gong;Jynho Kim

  • Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea

    Michael J. McCullough;Karl V. Clemons;David A. Stevens

  • Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.

    Eveline C van Asbeck;Karl V Clemons;David A Stevens

  • Genetic Characterization of Pathogenic Saccharomyces Cerevisiae Isolates

    J H McCusker;K V Clemons;D A Stevens;R W Davis

  • Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis

    Karl V. Clemons;Karl V. Clemons;Marife Espiritu;Rachana Parmar;David A. Stevens;David A. Stevens

  • Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis.

    K V Clemons;E Brummer;D A Stevens

  • Restriction Endonuclease Analysis of Total Cellular DNA of Aspergillus fumigatus Isolates of Geographically and Epidemiologically Diverse Origin

    David W. Denning;Karl V. Clemons;Linda H. Hanson;David A. Stevens

  • Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source,and review of published studies

    Eveline C. van Asbeck;Eveline C. van Asbeck;Eveline C. van Asbeck;Yhu-Chering Huang;Angela N. Markham;Angela N. Markham;Karl V. Clemons;Karl V. Clemons

  • Hormones and the Resistance of Women to Paracoccidioidomycosis

    Jata Shankar;Jata Shankar;Angela Restrepo;Karl V. Clemons;Karl V. Clemons;David A. Stevens;David A. Stevens

  • Species Identification and Virulence Attributes of Saccharomyces boulardii (nom. inval.)

    Michael J. McCullough;Karl V. Clemons;Karl V. Clemons;John H. McCusker;David A. Stevens;David A. Stevens

  • Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae.

    J H McCusker;K V Clemons;D A Stevens;R W Davis

  • Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

    K. V. Clemons;G. Grunig;R. A. Sobel;L. F. Mirels

  • Comparative Pathogenesis of Clinical and Nonclinical Isolates of Saccharomyces cerevisiae

    Karl V. Clemons;John H. McCusker;Ronald W. Davis;David A. Stevens

  • Efficacy of Micafungin Alone or in Combination against Systemic Murine Aspergillosis

    Javier Capilla Luque;Karl V. Clemons;Karl V. Clemons;David A. Stevens;David A. Stevens

  • Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis

    Karl V. Clemons;Marife Espiritu;Rachana Parmar;David A. Stevens;David A. Stevens

  • Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.

    J E Lutz;K V Clemons;B H Aristizabal;D A Stevens

  • Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods.

    K V Clemons;F Feroze;K Holmberg;D A Stevens

  • Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for Treatment of Systemic Murine Cryptococcosis

    Karl V. Clemons;David A. Stevens

  • The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence

    K. V. Clemons;K. V. Clemons;D. A. Stevens;D. A. Stevens

  • Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations.

    J S Hostetler;J Heykants;K V Clemons;R Woestenborghs

Frequent Co-Authors

David A. Stevens
David A. Stevens Stanford University
Raymond A. Sobel
Raymond A. Sobel Stanford University
Lisa A. Tell
Lisa A. Tell University of California, Davis
John H. McCusker
John H. McCusker Duke University
Demosthenes Pappagianis
Demosthenes Pappagianis University of California, Davis
Elmer Brummer
Elmer Brummer Santa Clara Valley Medical Center
Malcolm Richardson
Malcolm Richardson University of Manchester
Richard B. Moss
Richard B. Moss Stanford University
Ronald W. Davis
Ronald W. Davis Stanford University
David Feldman
David Feldman Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary fields, some of which can be pursued through online healthcare degrees. These programs offer flexibility for students balancing work or personal commitments while gaining essential medical knowledge that complements microbiology expertise.

For those interested in public health aspects of microbiology, exploring mph online programs with easy admission requirements can provide an accessible pathway. These programs blend epidemiology, disease prevention, and policy, aligning well with microbiological principles in real-world health challenges.

Career pathways like becoming a certified child life specialist may also intrigue microbiology graduates who want to work in healthcare environments supporting patients and families. Understanding the process of ccls certification can be a valuable step toward this meaningful profession.

Moreover, students with unique backgrounds might wonder, what is the best degree for a convicted felon. Fortunately, many online programs and career options accommodate non-traditional students, including those with criminal records, helping them build rewarding careers in science and healthcare.

Best Scientists Citing Karl V. Clemons

Trending Scientists

Recently Published Articles